When reintroduced, PEDF (which is commonly downregulated in prostate cancer cells) decreased the rate of proton (H+) fluxes (function of V-ATPases) in metastatic prostate cancer cells without affecting it in non-metastatic counterparts [7]. This evidence concerns the gene SERPINF1 and prostate carcinoma.